Protective Effect of Xinjiang Bactrian Camel Milk on the Liver of Streptozotocin-Induced Diabetic Mice

被引：0
|
作者：
Liu C. [1 ]
Feng X. [1 ]
Dou Z. [1 ]
An S. [1 ]
Liu M. [1 ]
Hou Z. [2 ]
Yang J. [1 ]
机构：
[1] College of Life Science and Technology, Xinjiang University, Ürümqi
[2] Department of Geriatrics, The Second Affiliated Hospital of Xinjiang Medical University, Ürümqi
来源：
Yang, Jie (yangjie234@xju.edu.cn) | 1600年 / Chinese Chamber of Commerce卷 / 41期
关键词：
Camel milk; Liver injury; Peroxisome proliferator-activated receptor γ; Sterol regulatory element binding protein 1c; Type; 1; diabetic;
D O I：
10.7506/spkx1002-6630-20190322-293
中图分类号：
学科分类号：
摘要：
In this research, the effect of whole milk, skim milk, milk casein, whey and whey proteins from bactrian camels in Xinjiang on glycolipid metabolism, antioxidant status, hepatocyte morphology, and the mRNA expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) and sterol regulatory element binding protein 1c (SREBP1c) in streptozotocin (STZ)-induced type 1 diabetic mice was investigated. The results showed that all samples except camel milk casein could increase the body mass of diabetic mice, reduce blood sugar, increase serum insulin level, restore blood lipid levels to normal, improve liver antioxidant capacity, and reduce liver tissue damage. In terms of these indicators, the whey treatment group differed more significantly from the model group than did other treatment groups (P < 0.01). Camel whey could increase the expression of PPAR-γ and reduce the expression of SREBP1c in the liver of diabetic mice. In summary, camel whey could effectively improve glycolipid metabolism and relief liver tissue damage in STZ-induced diabetic mice and its effect might be related to the up-regulation of PPAR-γ and the down-regulation of SREBP1c. © 2020, China Food Publishing Company. All right reserved.
引用
收藏
页码：74 / 80
页数：6
相关论文
共 30 条
  • [21] TANG A, RABASA-LHORET R, CASTEL H, Et al., Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial[J], Diabetes Care, 38, 7, pp. 1339-1346, (2015)
  • [22] BESSE-PATIN A, ESTALL J L., An intimate relationship between ROS and insulin signalling: implications for antioxidant treatment of fatty liver disease, International Journal of Cell Biology, 2014, pp. 1-9, (2014)
  • [23] KAST-WOELBERN H R, DANA S L, CESARIO R M, Et al., Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor γ and sterol regulatory element-binding protein in the regulation of adipogenesis, Journal of Biological Chemistry, 279, 23, pp. 23908-23915, (2004)
  • [24] GROSS B, PAWLAK M, LEFEBVRE P, Et al., PPARs in obesityinduced T2DM, dyslipidaemia and NAFLD[J], Nature Reviews Endocrinology volume, 13, 1, pp. 36-49, (2017)
  • [25] CAI W, YANG T, LIU H, Et al., Peroxisome proliferator activated receptor γ (PPARγ): a master gatekeeper in CNS injury and repair, Progress in Neurobiology, 163, 164, pp. 27-58, (2018)
  • [26] VILLAPOL S., Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation, Cellular and Molecular Neurobiology, 38, pp. 121-132, (2017)
  • [27] GEE V M, WONG F S, RAMACHANDRAN L, Et al., Identification of novel peroxisome proliferator-activated receptor-gamma (PPARγ)agonists using molecular modeling method, Journal of Computer-Aided Molecular Design, 28, 11, pp. 1143-1151, (2014)
  • [28] MUTHUKUMARAN P, THIYAGARAJAN G, ARUN BABU R L, Et al., Raffinose from Costus speciosus attenuates lipid synthesis through modulation of PPARs/SREBP1c and improves insulin sensitivity through PI3K/AKT, Chemico-Biological Interactions, 284, pp. 80-89, (2018)
  • [29] ZHAO R, JIN R, CHEN Y, Et al., Hypoglycemic and hypolipidemic effects of Lycium barbarum polysaccharide in diabetic rats, Chinese Herbal Medicines, 7, 4, pp. 310-315, (2015)
  • [30] LEE G, JANG H, KIM Y Y, Et al., SREBP1c-PAX4 axis mediates pancreatic β-cell compensatory responses upon metabolic stress, Diabetes, 68, 1, pp. 81-94, (2019)
123